Senior insider sale
Chief Business Dev. Officer at SUTRO BIOPHARMA, INC. — senior position signals high conviction
$131.0K
8.93K shares
What this filing means
LEYMAN BARBARA plans to sell 8.93K shares of SUTRO BIOPHARMA, INC. valued at approximately $131.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/20/2026ACC: 0001950047-26-000550
Officer· Chief Business Dev. Officer
Since Jul 2024
8.93K
Shares to sell
$131.0K
Approx. market value
8.93K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Stock Option Exercise
Cash
1/20/2026
4.36KRestricted Stock
Not Applicable
11/21/2025
1.61KRestricted Stock
Not Applicable
11/21/2025
1.36KRestricted Stock
Not Applicable
7/8/2025
1.61KTotal acquired8.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/20/2026 | Stock Option Exercise Cash | 4.36K | — |
11/21/2025 | Restricted Stock Not Applicable | 1.61K | — |
11/21/2025 | Restricted Stock Not Applicable | 1.36K | — |
7/8/2025 | Restricted Stock Not Applicable | 1.61K | — |
| Total | 8.93K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.93K
Market value
$131.0K
1/20/2026
Total
Units
8.93K
Value
$131.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/20/2026 | 8.93K | $131.0K | NASDAQ | Planned |
| Total | 8.93K | $131.0K | ||